EXAS has been granted a new patent
Dec 25, 2024, 11:32 PM
-5.13%
What does EXAS do
EXACT Sciences, headquartered in Madison, Wisconsin, focuses on cancer screening and diagnostics, employing 6,500 people. Its key products include the Cologuard test for colorectal cancer and Oncotype DX tests for breast cancer.
EXAS filed a patent for "compositions and methods for signal-amplified flap cleavage assays" on Fri, January 27, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.